title: Hepatic paraoxonase activity alterations and free radical production in rats with experimental cirrhosis.
abstract: Relationships between hepatic antioxidant paraoxonase (PON1) activity, lipid peroxidation, and liver injury were investigated in rats with CCl(4)-induced cirrhosis. The study was performed in 60 CCl(4)-treated rats and 60 control animals receiving a standard diet or one supplemented with zinc. Subsets of 10 animals each were killed at weeks 1, 5, and 7 of the study. Results showed that PON1 significantly decreased in rats given CCl(4) alone compared with control animals. This effect was partially reversed in animals receiving zinc. Conversely, lipid peroxides were significantly increased in rats given CCl(4) alone and returned to approximately normal values in animals receiving zinc supplement. PON1 was inversely correlated with lipid peroxidation in all the animals studied. These alterations coincided with changes in serum alanine aminotransferase activity. In vitro incubation of isolated microsomes with CCl(4) or malondialdehyde did not produce any significant changes in PON1, indicating that the decrease in PON1 in CCl(4)-treated animals was not secondary to a direct inhibitory effect of lipid peroxidation products. These data show a time course and quantitative relationship between PON1 activity and lipid peroxidation in rats with CCl(4)-induced cirrhosis and suggest that this enzyme plays a significant role within the antioxidant systems in liver microsomes.
authors.affiliation: Centre de Recerca Biomèdica, Institut de Recerca en Ciències de la Salut (IRCIS), Hospital Universitari de Sant Joan de Reus, Catalunya, Spain.
authors.forename: N
authors.initials: N
authors.lastname: Ferré
authors.forename: J
authors.initials: J
authors.lastname: Camps
authors.forename: M
authors.initials: M
authors.lastname: Cabré
authors.forename: A
authors.initials: A
authors.lastname: Paul
authors.forename: J
authors.initials: J
authors.lastname: Joven
mesh_terms: D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D043303:Aryldialkylphosphatase; D002251:Carbon Tetrachloride; D019587:Dietary Supplements; D004789:Enzyme Activation / Q000187:drug effects; D004950:Esterases / Q000378:metabolism*; D005609:Free Radicals / Q000378:metabolism*; D015227:Lipid Peroxidation / Q000187:drug effects; D008054:Lipid Peroxides / Q000378:metabolism; D008099:Liver / Q000737:chemistry / Q000201:enzymology* / Q000473:pathology; D008106:Liver Cirrhosis, Experimental / Q000097:blood / Q000139:chemically induced / Q000201:enzymology*; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism / Q000494:pharmacology; D008862:Microsomes, Liver / Q000737:chemistry / Q000201:enzymology; D051381:Rats; D015032:Zinc / Q000008:administration & dosage
chemical_list: D005609:Free Radicals; D008054:Lipid Peroxides; D008315:Malondialdehyde; D002251:Carbon Tetrachloride; D000410:Alanine Transaminase; D004950:Esterases; D043303:Aryldialkylphosphatase; C468406:PON1 protein, human; D015032:Zinc